| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 2 | |||
| NCT06456463 | A Study of Tagraxofusp in Combination With Venetoclax and Azacitidine in Adults With… | Acute Myeloid Leukemia | Recruiting |
| NCT05442216 | Tagraxofusp and Azacitidine With Venetoclax in Newly Diagnosed Secondary AML After… | Acute Myeloid Leukemia | Recruiting |
| NCT04216524 | Venetoclax, SL-401, and Chemotherapy for the Treatment of Blastic Plasmacytoid Dendritic… | Blastic Plasmacytoid Dendritic Cell Neoplasm | Recruiting |
| Phase 1/2 | |||
| NCT07148180 | A Multi-Site Break Through Cancer Trial: Targeting Measurable Residual Disease in… | Acute Myeloid Leukaemia (AML) | Recruiting |
| NCT06561152 | Tagraxofusp and Low-Intensity Chemotherapy for CD123-Positive Relapsed or Refractory AML | Refractory Acute Myeloid Leukemia | Recruiting |
| NCT05038592 | Phase I/II Study of Tagraxofusp in Combination With Decitabine for Patients With… | Chronic Myelomonocytic Leukemia | Active, Not Recruiting |
| Phase 1 | |||
| NCT06498973 | Tagraxofusp and Azacitidine for Maintenance Treatment in Patients With CD123 Positive AML… | Acute Myeloid Leukemia | Recruiting |
| Early Phase 1 | |||
| NCT06414681 | Combination of Tagraxofusp With Pacritinib in Patients With Intermediate-1 or Higher… | Myelofibrosis，MF | Recruiting |